stoxline Quote Chart Rank Option Currency Glossary
Minerva Surgical, Inc. (UTRS)
1.48  0 (0%)    07-18 16:00
Open: 0.001
High: 1.48
Volume: 1
Pre. Close: 1.48
Low: 0.001
Market Cap: 13(M)
Technical analysis
2024-07-19 1:54:02 PM
Short term     
Mid term     
Targets 6-month :  1.72 1-year :  2.01
Resists First :  1.48 Second :  1.72
Pivot price 0.2
Supports First :  0.56 Second :  0
MAs MA(5) :  0.59 MA(20) :  0.15
MA(100) :  0.33 MA(250) :  1.87
MACD MACD :  0.1 Signal :  0
%K %D K(14,3) :  100 D(3) :  100
RSI RSI(14): 84.2
52-week High :  6.15 Low :  0
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ UTRS ] has closed above the upper band by 13.7%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 322.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.48 - 1.49 1.49 - 1.49
Low: 0 - 0 0 - 0
Close: 1.47 - 1.48 1.48 - 1.49
Company Description

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Headline News

Mon, 18 Dec 2023
Why Is Minerva Surgical (UTRS) Stock Down 50% Today? - InvestorPlace

Wed, 24 May 2023
Why Is Minerva Surgical (UTRS) Stock Up 229% Today? - InvestorPlace

Thu, 23 Mar 2023
Minerva Surgical names Kaile Zagger chief commercial officer - Mass Device

Thu, 09 Feb 2023
Minerva Surgical closes $30M financing, has new controlling stockholder - Mass Device

Thu, 29 Dec 2022
Minerva Surgical Chief Executive David Clapper Retires; Todd Usen Appointed Successor -

Thu, 29 Dec 2022
Minerva Surgical CEO retires, former Activ Surgical head Todd Usen named as replacement - Mass Device

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Healthcare Information Services
Shares Out 9 (M)
Shares Float 3 (M)
Held by Insiders 0.4 (%)
Held by Institutions 70 (%)
Shares Short 37 (K)
Shares Short P.Month 2 (K)
Stock Financials
EPS -7.62
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.27
Profit Margin -64.8 %
Operating Margin -51 %
Return on Assets (ttm) -27.4 %
Return on Equity (ttm) -160.1 %
Qtrly Rev. Growth -5 %
Gross Profit (p.s.) 0
Sales Per Share 5.82
EBITDA (p.s.) -2.88
Qtrly Earnings Growth 0 %
Operating Cash Flow -39 (M)
Levered Free Cash Flow -18 (M)
Stock Valuations
PE Ratio -0.2
PEG Ratio 0
Price to Book value 0.64
Price to Sales 0.25
Price to Cash Flow -0.34
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android